BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Report

HEMEMICS BIOTECHNOLOGIES, INC.

via BURRELL INTERNATIONAL GROUP LLC

1st Quarter (Jan 1 - Mar 31) · 2021Posted Apr 19, 2021Filing document ↗LDA record ↗

Income$20Kfee reported

Client

Name: HEMEMICS BIOTECHNOLOGIES, INC.
Description: Biotechnology Firm
Location: Maryland · United States of America

Registrant

Firm: BURRELL INTERNATIONAL GROUP LLC
Description: Government Affairs Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medical/Disease Research/Clinical Labs
COVID Stimulus Funding for Diagnostics and LHHS Next Generation Diagnostic Funding
LobbyistsDEBORAH LYNN BURRELL
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

HEMEMICS BIOTECHNOLOGIES, INC. — Lobbying — Receipts Report